HealthcareMRR2

Bone Metastasis Market The increasing prevalence of breast cancer, growing geriatric population, rising healthcare expenditures, and increasing R&D expenses by the key players are estimated to drive the market growth during the forecast period. The Bone Metastasis Market is expected to reach USD 17.5 Billion by 2032 at 9.4% CAGR during the forecast period 2023-2032 Bone metastasis is a condition that occurs when cancerous cells from a non-bone site travel, i.e. metastasize, to bones. The spine, particularly the lower spine, the pelvis, and the thighs, are the most common sites for bone metastases. Bone metastasis can cause urinary and bowel incontinence, due to it being located quite close to both the urinary bladder and the rectal column, as well as hypercalcemia. While all cancers can manifest in this way, breast and prostate cancers are the likeliest sources of bone metastasis – 65-75% of patients suffering from breast or prostate cancers experience bone metastasis. The b...

Cortisone Shots Market The Cortisone Shots Market Size is expected to reach USD 6,328.3 Million by 2030 at 7.2% CAGR during the forecast period 2022-2030. The rise in the incidence of chronic diseases such as rheumatoid arthritis, tendonitis and bursitis, the increase in the number of joint, muscle and tendon injuries and the emergence of major players on the market are significant reasons for accelerating market growth. Due to the growing prevalence of arthritis among the elderly, the rising geriatric population is another primary factor for demand development. However, there are a range of drawbacks to cortisone shoots, such as damage to tendons , ligaments and articular cartilage, thereby limiting market growth. The main factors driving the global cortisone shots demand are strong unmet requirements, increased incidence of bone and joint diseases, government awareness campaigns for joint disorders, increased obese population due to unhealthy behaviours, and advantageous healt...